Parnassus Investments Buys Gilead Sciences Inc, AbbVie Inc, Thomson Reuters Corp, Sells Starbucks Corp, Sempra Energy, United Parcel Service Inc

• New Purchases: ABBV, TRI, REGN,
• Added Positions: GILD, CERN, BIIB, PRGO, XRAY, SYY, AAPL, NVDA, SEIC, COF, QCOM, MA, NWN, IBM, NLSN, MKC, AXTA, SJR, EXPD, FTV, TFX,
• Reduced Positions: SBUX, UPS, CVS, CELG, WDFC, AGN, LRCX, AXP, IPGP, MSI, HBI, GOOGL, MDU, SNPS, PNR, FRC, PPG, PSA, BEL, MAT, SREPA.PFD, ZAYO,
• Sold Out: SRE, TOCB, BMY,

For the details of PARNASSUS INVESTMENTS 's stock buys and sells, go to https://www.gurufocus.com/guru/parnassus+investments+/current-portfolio/portfolio

1. Cadence Design Systems Inc (CDNS) - 14,385,382 shares, 3.60% of the total portfolio. Shares reduced by 0.05%
2. Linde PLC (LIN) - 4,995,873 shares, 3.47% of the total portfolio. Shares reduced by 0.67%
3. Gilead Sciences Inc (GILD) - 13,074,555 shares, 3.35% of the total portfolio. Shares added by 21.22%
4. The Walt Disney Co (DIS) - 7,109,165 shares, 3.11% of the total portfolio. Shares reduced by 0.07%
5. Synopsys Inc (SNPS) - 6,723,664 shares, 3.05% of the total portfolio. Shares reduced by 1.05%

Parnassus Investments initiated holding in AbbVie Inc. The purchase prices were between $77.14 and $92.19, with an estimated average price of $82.08. The stock is now traded at around $78.88. The impact to a portfolio due to this purchase was 0.54%. The holding were 1,700,000 shares as of .

Parnassus Investments initiated holding in Thomson Reuters Corp. The purchase prices were between $46.87 and $59.2, with an estimated average price of $52.89. The stock is now traded at around $61.58. The impact to a portfolio due to this purchase was 0.49%. The holding were 2,080,175 shares as of .

Parnassus Investments initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $372.08 and $439.57, with an estimated average price of $411.49. The stock is now traded at around $340.79. The impact to a portfolio due to this purchase was 0.26%. The holding were 160,000 shares as of .

Parnassus Investments added to a holding in Gilead Sciences Inc by 21.22%. The purchase prices were between $62.53 and $70.05, with an estimated average price of $66.46. The stock is now traded at around $64.87. The impact to a portfolio due to this purchase was 0.59%. The holding were 13,074,555 shares as of .

Parnassus Investments added to a holding in Biogen Inc by 80.00%. The purchase prices were between $216.71 and $338.96, with an estimated average price of $315.3. The stock is now traded at around $229.50. The impact to a portfolio due to this purchase was 0.26%. The holding were 630,000 shares as of .

Parnassus Investments added to a holding in Perrigo Co PLC by 77.27%. The purchase prices were between $38.75 and $50.22, with an estimated average price of $46.69. The stock is now traded at around $48.54. The impact to a portfolio due to this purchase was 0.16%. The holding were 1,950,000 shares as of .

Parnassus Investments added to a holding in Dentsply Sirona Inc by 69.17%. The purchase prices were between $37.21 and $50.02, with an estimated average price of $43.87. The stock is now traded at around $50.31. The impact to a portfolio due to this purchase was 0.12%. The holding were 1,553,139 shares as of .

Parnassus Investments added to a holding in SEI Investments Co by 25.41%. The purchase prices were between $44.41 and $52.9, with an estimated average price of $50.03. The stock is now traded at around $53.72. The impact to a portfolio due to this purchase was 0.07%. The holding were 1,590,474 shares as of .

Parnassus Investments added to a holding in Capital One Financial Corp by 36.67%. The purchase prices were between $75.59 and $84.97, with an estimated average price of $81.25. The stock is now traded at around $92.58. The impact to a portfolio due to this purchase was 0.07%. The holding were 820,000 shares as of .

Parnassus Investments sold out a holding in Sempra Energy. The sale prices were between $106.76 and $126.07, with an estimated average price of $117.55.

Parnassus Investments sold out a holding in Thomson Reuters Corp. The sale prices were between $40.99 and $52.35, with an estimated average price of $46.31.

Parnassus Investments sold out a holding in Bristol-Myers Squibb Company. The sale prices were between $45.12 and $53.8, with an estimated average price of $49.88.